Halberd's patented process demonstrates eradication of multiple strains of antibiotic resistant bacteria and fungi in under 10 minutes.JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation
A new weapon in the arsenal of cancer cells treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is the ability for them to respond randomly to chemotherapy.
According to recent research led by the Garvan Institute of Medical Research, cancer cells have an inbuilt randomness in their capacity to respond to chemotherapy, which is another weapon in their treatment resistance toolbox.
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions